Clinical Evidence
Measure of Safety for Q2Hour vs Q1Hour Glucose Checks for Intravenous Insulin Dosing
Objective
This retrospective study compares the safety and efficacy of two-hour blood glucose checks (q2hour) to one-hour blood glucose checks (q1hour) with use of an electronic glucose management system (EndoTool) for intravenous insulin dosing.
Setting
Cohort of five unaffiliated acute care hospitals.
Results
- Incidence of hypoglycemia <70 mg/dL was lower for q2hour checks than q1hour checks (0.24% vs 0.29% of blood glucose readings).
- Percentage of blood glucose readings more than 5 minutes late was lower for q2hour checks than q1hour checks (38.7% vs 44.3%).
- Mean blood glucose was lower for q2hour checks than q1hour checks (126 mg/dL vs 149 mg/dL).
- Variance from mean was lower for q2hour checks than q1hour checks (20% vs 25%).
Conclusions
Measures of hypoglycemia and blood glucose control observed with q2hour checks are superior to q1hour checks, affirming that EndoTool recommendations for q2hour checks are appropriate and hospitals can enjoy a positive impact to nursing workflow and reduced costs of care.
References
Authors
W. Patrick Burgess; Laura Santana; Chris Santry; Cathy Jaynes; Laurel Fuqua.
Source
Presented at American Association of Clinical Endocrinologists Scientific & Clinical Congress.
Year
2019
Related posts
Clinical Evidence
Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment
Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment
Clinical Evidence
Achieving Optimal Glucose Control in Critical Care Units at Atrium Health
Achieving Optimal Glucose Control in Critical Care Units at Atrium Health
Clinical Evidence
Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings
Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings
Get in Touch
Ready to get started?
"*" indicates required fields